Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D00RNB
|
|||
Former ID |
DIB000931
|
|||
Drug Name |
IQB-9302
|
|||
Indication | Pain [ICD-11: MG30-MG3Z] | Phase 1 | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C18H26N2O
|
|||
Canonical SMILES |
CC1=C(C(=CC=C1)C)NC(=O)C2CCCCN2CC3CC3
|
|||
InChI |
1S/C18H26N2O/c1-13-6-5-7-14(2)17(13)19-18(21)16-8-3-4-11-20(16)12-15-9-10-15/h5-7,15-16H,3-4,8-12H2,1-2H3,(H,19,21)
|
|||
InChIKey |
DNUYDQISHIJMLD-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 166181-63-1
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Voltage-gated potassium channel Kv1.5 (KCNA5) | Target Info | Opener | [1] |
Pathwhiz Pathway | Muscle/Heart Contraction | |||
Reactome | Voltage gated Potassium channels | |||
WikiPathways | Potassium Channels |
References | Top | |||
---|---|---|---|---|
REF 1 | Stereoselective effects of the enantiomers of a new local anaesthetic, IQB-9302, on a human cardiac potassium channel (Kv1.5). Br J Pharmacol. 2001 Jan;132(2):385-92. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.